Correction : Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer
[This corrects the article DOI: 10.18632/oncotarget.23507.].
| Errataetall: |
ErratumFor: Oncotarget. 2017 Dec 20;9(2):2515-2526. - PMID 29416788 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Oncotarget - 11(2020), 37 vom: 15. Sept., Seite 3484-3485 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hu, Yuzhu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 25.09.2020 published: Electronic-eCollection ErratumFor: Oncotarget. 2017 Dec 20;9(2):2515-2526. - PMID 29416788 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18632/oncotarget.27605 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315447605 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315447605 | ||
| 003 | DE-627 | ||
| 005 | 20231225154932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.27605 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315447605 | ||
| 035 | |a (NLM)32973972 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hu, Yuzhu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Oncotarget. 2017 Dec 20;9(2):2515-2526. - PMID 29416788 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a [This corrects the article DOI: 10.18632/oncotarget.23507.] | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Yu, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xiaoxiao |e verfasserin |4 aut | |
| 700 | 1 | |a He, Yihong |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Lihong |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Jiajuan |e verfasserin |4 aut | |
| 700 | 1 | |a Hua, Yuanqi |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Xiang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 11(2020), 37 vom: 15. Sept., Seite 3484-3485 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g number:37 |g day:15 |g month:09 |g pages:3484-3485 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.27605 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |e 37 |b 15 |c 09 |h 3484-3485 | ||